A phase III trial to study Esophageal Adenocarcinoma

This study is being done to compare the effects, good and/or bad, of the addition of trastuzumab to standard chemotherapy, radiation, and surgery for patients with HER2 positive esophageal cancer.
BH-11-211
Cancer - Esophogus, Cancer
Seth Kaufman, MD
D’Amour Center for Cancer Care
3350 Main Street
Springfield MA 01199
This study is being done to compare the effects, good and/or bad, of the addition of trastuzumab to standard chemotherapy, radiation, and surgery for patients with HER2 positive esophageal cancer.

Participants must have confirmed esophageal cancer, HER2 positive, and no prior chemotherapy or radiation.

Rae Lynn Defeo
413-794-0255